Inogen (INGN) Cash from Investing Activities (2013 - 2026)

Inogen's (INGN) quarterly Cash from Investing Activities came in at -$2.0 million in Q1 2026, up 3.09% year-on-year from -$1.9 million in Q1 2025, and down 30.28% on a QoQ basis from -$1.5 million in Q4 2025.

Inogen (INGN) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Inogen (INGN) has 14 years of Cash from Investing Activities data on file, last reported at -$2.0 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 3.09% year-over-year to -$2.0 million in Q1 2026; TTM through Mar 2026 was -$26.1 million, a 917.75% decrease from a year earlier, with the FY2025 full-year figure at -$26.2 million, down 87.54% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$2.0 million, down from -$1.5 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for INGN reached as high as $11.5 million in Q4 2024 and fell as low as -$45.8 million in Q3 2023.
  • Historically, Cash from Investing Activities has averaged -$6.6 million across 5 years, with a median of -$2.0 million in 2025.
  • Across the five-year window, Cash from Investing Activities jumped 210.57% in 2022 and sank 2191.85% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$6.9 million in 2022, then jumped by 159.45% to $4.1 million in 2023, then jumped by 179.55% to $11.5 million in 2024, then tumbled by 113.14% to -$1.5 million in 2025, then sank by 30.28% to -$2.0 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$2.0 million in Q1 2026, -$1.5 million in Q4 2025, and -$82000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Inogen 173.63 Mn 63.46 Mn 37.86 Mn -1.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.98 Mn
Mar 31, 2026 -1.98 Mn
Dec 31, 2025 -1.52 Mn
Dec 31, 2025 -1.52 Mn
Sep 30, 2025 -82,000.00
Sep 30, 2025 -82,000.00
Jun 30, 2025 -22.57 Mn
Jun 30, 2025 -22.57 Mn
Mar 31, 2025 -2.04 Mn
Mar 31, 2025 -2.04 Mn
Dec 31, 2024 11.54 Mn
Dec 31, 2024 11.54 Mn
Sep 30, 2024 305,000.00
Sep 30, 2024 305,000.00
Jun 30, 2024 -12.38 Mn
Jun 30, 2024 -12.38 Mn
Mar 31, 2024 -13.44 Mn
Mar 31, 2024 -13.44 Mn
Dec 31, 2023 4.13 Mn
Dec 31, 2023 4.13 Mn